Measuring HIV-1 RNA levels in various biological compartments of infected patients provides insight to viral shedding, transmission, reservoirs, and pathological manifestations. Commercial HIV-1 RNA quantitative assays approved by the FDA for plasma samples are often used to quantify HIV-1 RNA in non-plasma specimens. Endocervical swabs, for example, contain bacterial and human byproducts which may affect PCR amplification of HIV-1 and subsequently generate false negative results. In this study, we retrospectively investigated endocervical swab results tested by the Abbott RealTime HIV-1 assay (Abbott).
Abbott assay-derived HIV RNA results, cycle numbers (CN), MaxRatios (MR), and amplification graphs for 762 endocervical swab samples collected from HIV-1 infected female individuals within the first year of ART in Kenya and Uganda were analyzed. Plasma assay reported a numerical HIV RNA copy, based on the CN at which the amplification curve crossed the defined HIV threshold (ΔRn=0.010), for samples with MR≥ 0.070; samples with MR< 0.070 yielded a “not detected” result. Amplification profiles of default “not detected” samples were visually evaluated one-by-one; if their curves crossing the threshold, CNs were estimated, otherwise samples’ results were determined be HIV-1 negative.
One hundred and fifty six endocervical swabs were detected to be HIV positive using the default cutoff and confirmed upon observation of the amplification curve crossing the threshold (Table 1). Among 606 default “not detected” endocervical swab samples, 188 (31%) swab samples were found to contain amplification curves crossing the threshold with MR ranging 0.011 to 0.068; 64 swab samples had HIV RNA ranging from 2.49 to 4.29 log10copies/swab, and 124 swab samples had < 2.39 log10copies/swab. PCR interfering agents may cause more flat amplification profiles for swab samples, resulting in lower MR values and failing the default criterion.
In addition to HIV RNA results, the Abbott HIV-1 assay provided MR values and amplification graphs useful for examining non-plasma sample results. Thus, in this study an additional 188 HIV positive endocervical swab were identified; HIV RNA positivity significantly increased from 20% (156/762) to 45% (344/762) in swabs collected from infected female individuals after initiation of ART, implying a greater rate of genital shedding than previously reported.